Joined Fojann Biopharmaceuticals limited in February 2025 as Chief Scientist.
Chairman of Shanghai Lishan Biomedicine Co., Ltd. Postdoctoral Researcher, Institute of Intelligent Medicine, Fudan University. Holds a Ph.D. in Biophysics from Brown University, USA, Albert Einstein College of Medicine. Previously worked at the Swiss publishing group Frontiers as a Medical Journal Development Manager, responsible for organizing special issue submissions for journals such as Frontiers in Immunology, Frontiers in Nutrition, and Frontiers in Veterinary Science. Formerly a Research Assistant at the Cancer Center at Albert Einstein College of Medicine in New York.